QT interval dispersion as a new marker of restenosis after percutaneous transluminal coronary angioplasty

被引:1
|
作者
Grygier, M
Lesiak, M
Podzerek, T
Kowal, J
Pyda, M
Skorupski, W
Grajek, S
Cieslinski, A
机构
[1] Poznan Tech Univ, Sch Med Sci, Dept Cardiol, PL-60965 Poznan, Poland
[2] Poznan Tech Univ, Sch Med Sci, Dept Clin Pharmacol, PL-60965 Poznan, Poland
关键词
D O I
10.1016/S0195-668X(03)96129-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:684 / 684
页数:1
相关论文
共 50 条
  • [31] FACTORS AFFECTING THE RESTENOSIS RATE AFTER PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY
    BACH, R
    JUNG, F
    KOHSIEK, I
    OZBEK, C
    SPITZER, S
    SCHELLER, B
    DYCKMANS, J
    SCHIEFFER, H
    THROMBOSIS RESEARCH, 1994, 74 : S55 - S67
  • [32] Effectiveness of an antioxidant in preventing restenosis after percutaneous transluminal coronary angioplasty: The Probucol Angioplasty Restenosis Trial
    Yokoi, H
    Daida, H
    Kuwabara, Y
    Nishikawa, H
    Takatsu, F
    Tomihara, H
    Nakata, Y
    Kutsumi, Y
    Ohshima, S
    Nishiyama, S
    Seki, A
    Kato, K
    Nishimura, S
    Kanoh, T
    Yamaguchi, H
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 30 (04) : 855 - 862
  • [33] LIPOPROTEIN(A) IS NOT A RISK FACTOR FOR RESTENOSIS AFTER PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY
    SCHUMACHER, M
    TIRAN, A
    EBER, B
    TOPLAK, H
    WILDERSTRUSCHNIG, M
    KLEIN, W
    AMERICAN JOURNAL OF CARDIOLOGY, 1992, 69 (05): : 572 - 572
  • [34] Pulse pressure as a predictor of restenosis after percutaneous transluminal coronary angioplasty
    Bryniarski, L
    Jankowski, P
    Czarnecka, D
    Zabojszcz, M
    Kawecka-Jaszcz, K
    JOURNAL OF HYPERTENSION, 2002, 20 : S158 - S158
  • [35] Thrombin activation and late restenosis after percutaneous transluminal coronary angioplasty
    Salvioni, A
    Galli, S
    Marenzi, G
    Lauri, G
    Perego, GB
    Assanelli, E
    Guazzi, MD
    AMERICAN HEART JOURNAL, 1998, 135 (03) : 503 - 509
  • [36] Genetic predictive factors for restenosis after percutaneous transluminal coronary angioplasty
    Monraats, PS
    Agema, WRP
    Zwinderman, AH
    de Winter, RJ
    Tio, RA
    Doevendans, PAFM
    Crijns, HJGM
    de Maat, MPM
    Atsma, DE
    van der Laarse, A
    van der Wall, EE
    Jukema, JW
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 53A - 53A
  • [37] PREDICTIVE FACTORS OF RESTENOSIS AFTER MULTIVESSEL PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY
    LEFEUVRE, C
    BONAN, R
    LESPERANCE, J
    GOSSELIN, G
    JOYAL, M
    CREPEAU, J
    AMERICAN JOURNAL OF CARDIOLOGY, 1994, 73 (12): : 840 - 844
  • [38] Effect of cilostazol in preventing restenosis after percutaneous transluminal coronary angioplasty
    Take, S
    Matsutani, M
    Ueda, H
    Hamaguchi, H
    Konishi, H
    Baba, Y
    Kawaratani, H
    Sugiura, T
    Iwasaka, T
    Inada, M
    AMERICAN JOURNAL OF CARDIOLOGY, 1997, 79 (08): : 1097 - +
  • [39] Role of cytokines in the pathogenesis of restenosis after percutaneous transluminal coronary angioplasty
    Tashiro, H
    Shimokawa, H
    Sadamatsu, K
    Aoki, T
    Yamamoto, K
    CORONARY ARTERY DISEASE, 2001, 12 (02) : 107 - 113
  • [40] Detection of restenosis after percutaneous transluminal coronary angioplasty by an angiographic score
    Gottschall, CAM
    Miler, V
    Yordi, LM
    Cardoso, CR
    Rodrigues, LC
    JOURNAL OF INVASIVE CARDIOLOGY, 1998, 10 (01): : 1 - 11